Inari Medical Inc Ordinary Shares NARI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NARI is a good fit for your portfolio.
News
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sprout Social, and Inari and Encourages Investors to Contact the Firm
-
NASDAQ: NARI: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Lawsuit Filed Against Inari Medical, Inc.
-
INARI MEDICAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inari Medical, Inc. - NARI
-
Inari Medical, Inc. Investor Notice: Robbins LLP Remind Stockholders of the NARI Securities Fraud Class Action
-
Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – NARI
-
DEADLINE ALERT for SPT, NARI, and UNH: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
-
Inari Medical, Inc. (NARI) Litigation Initiated After NARI Disclosed DOJ Probe of Business Practices – Hagens Berman
-
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Inari Medical, Inc. (NARI) Investors
Trading Information
- Previous Close Price
- $46.30
- Day Range
- $45.69–46.52
- 52-Week Range
- $36.73–71.85
- Bid/Ask
- $43.00 / $47.14
- Market Cap
- $2.66 Bil
- Volume/Avg
- 887,809 / 1.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- 491.52
- Price/Sales
- 5.06
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,300
- Website
- https://www.inarimedical.com
Comparables
Valuation
Metric
|
NARI
|
ANIK
|
TCMD
|
---|---|---|---|
Price/Earnings (Normalized) | 491.52 | 127.00 | 25.23 |
Price/Book Value | 5.93 | 1.81 | 1.69 |
Price/Sales | 5.06 | 2.20 | 1.18 |
Price/Cash Flow | 105.58 | 19.98 | 16.46 |
Price/Earnings
NARI
ANIK
TCMD
Financial Strength
Metric
|
NARI
|
ANIK
|
TCMD
|
---|---|---|---|
Quick Ratio | 2.09 | 3.50 | 3.49 |
Current Ratio | 2.71 | 5.26 | 4.26 |
Interest Coverage | −98.60 | — | — |
Quick Ratio
NARI
ANIK
TCMD
Profitability
Metric
|
NARI
|
ANIK
|
TCMD
|
---|---|---|---|
Return on Assets (Normalized) | 2.99% | 0.92% | 11.37% |
Return on Equity (Normalized) | 3.92% | 1.13% | 17.93% |
Return on Invested Capital (Normalized) | 1.60% | 0.17% | 13.30% |
Return on Assets
NARI
ANIK
TCMD
Medical Devices Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ABT
| Abbott Laboratories | Ppvhmfsf | Rpvsdg | $181.1 Bil | |
SYK
| Stryker Corp | Jhghnvdzd | Xsd | $127.5 Bil | |
MDT
| Medtronic PLC | Dtgqxckjq | Hkscxbp | $113.7 Bil | |
BSX
| Boston Scientific Corp | Qpgqpvg | Qwwmxk | $109.6 Bil | |
EW
| Edwards Lifesciences Corp | Sfxqtfvbq | Vdhpg | $54.3 Bil | |
DXCM
| DexCom Inc | Jbcnvcms | Zwws | $52.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Xgdnsytt | Nxqdpq | $26.4 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Lbkpzvzhw | Qrqz | $24.7 Bil | |
ALGN
| Align Technology Inc | Lzygzcqb | Cmdxlbg | $20.6 Bil | |
PODD
| Insulet Corp | Jtymxpzfq | Dmdwgtk | $13.1 Bil |